Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 1-3

  Takeuchi, Tetsushiro ^a   Dohi, Kaoru ^a   Omori, Taku ^a   Moriwaki, Keishi ^a   Sato, Yuichi ^a   Nakamori, Shiro ^a   Fujimoto, Naoki ^a   Fujii, Eitaro ^a   Yamada, Norikazu ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Diuretics; Heart failure; Sodium glucose cotransporter 2 inhibitor

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; IPRAGLIFLOZIN; POTASSIUM ION; RENIN; SODIUM ION; DIURETIC AGENT; GLUCOSIDE; SLC5A2 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 2; THIOPHENE DERIVATIVE;

ADRENERGIC ACTIVITY; CLINICAL ARTICLE; GLOMERULUS FILTRATION RATE; GLUCOSE URINE LEVEL; HEART FAILURE; HEART WORK; HUMAN; ISCHEMIC CARDIOMYOPATHY; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA RENIN ACTIVITY; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; TREATMENT OUTCOME; URINALYSIS; URINE VOLUME; WEIGHT REDUCTION; AGED; ANTAGONISTS AND INHIBITORS; DIABETES MELLITUS, TYPE 2; FEMALE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIURETICS; FEMALE; GLUCOSIDES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SODIUM-GLUCOSE TRANSPORTER 2; THIOPHENES;

EID: 84943517417     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.072     Document Type: Article

References (10)

1. F. Zannad, S. Braincon, Y. Juilliere, P.M. Mertes, J.P. Villemot, F. Alla, and J.M. Virion Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study J. Am. Coll. Cardiol. 33 1999 734 742
2. B. Christophe, L. Nicolas, P. Mc F. Eugène, Eric Van Belle, M. Alain, and G. Pascal de Influence of diabetes mellitus on heart failure risk and outcome Cardiovasc. Diabetol. 2 2003 1
3. L. Solang, K. Malmberg, and L. Ryden Diabetes mellitus and congestive heart failure. Further knowledge needed Eur. Heart J. 20 1999 789 795
4. G.S. Francis, C. Benedict, D.E. Johnstone, P.C. Kirlin, J. Nicklas, C.S. Liang, S.H. Kubo, E. Rudintoretsky, and S. Yusuf Comparison of neuroendocrine activation in patients with left-ventricular dysfunction with and without congestive-heart-failure - a substudy of the studies of left-ventricular dysfunction (SOLVD) Circulation 82 1990 1724 1729
5. J. Bayliss, M. Norell, R. Canepaanson, G. Sutton, and P. Poolewilson Untreated Heart-failure - clinical and neuroendocrine effects of introducing diuretics Br. Heart J. 57 1987 17 22
6. K. Dohi, and M. Ito Novel diuretic strategies for the treatment of heart failure in Japan Circ. J. 78 2014 1816 1823
7. H.J. Lambers Heerspink, D. de Zeeuw, L. Wie, B. Leslie, and J. List Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes Diabetes Obes. Metab. 15 2013 853 862
8. Raymond V. Oliva, and George L. Bakris Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors J. Am. Soc. Hypertens. 8 2014 330 339
9. F. Biff Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system N. Engl. J. Med. 351 2004 585 592
10. W.Y. Clyde, J. Mariell, B. Biykem, B. Javed, E.C. Donald, H.D. Mark, C.F. Gregg, A.G. Stephen, H. Tamara, L.J. James, R.J. Maryl, K.K. Edward, C.L. Wayne, A.M. Frederick, E.M. Patrick, J.V.M. John, E.M. Judith, N.P. Pamela, R. Barbara, S. Flora, W.S. Lynne, W.H. Wilson Tang, J.T. Emily, and L.W. Bruce 2013 ACCF/AHA guideline for the management of heart failure J. Am. Coll. Cardiol. 62 2013 e173